Xia  Ding net worth and biography

Xia Ding Biography and Net Worth

Ms. Ding is currently the Managing Director of Greater China at Sephora. She joined Sephora in 2024 where she leads Sephora's business in Mainland China and Hong Kong SAR that spans around 350 stores, two e-commerce websites, and a robust ecosystem of digital platforms and apps. Prior to joining Sephora, Ms. Ding worked at Nike from 2019 to 2024 as the Vice President of e-commerce Asia Pacific and Latin America, where she was accountable for driving the Nike digital business in Asia Pacific and Latin America markets. Prior to Nike, Ms. Ding worked for JD.com in China from 2017 to 2019 as the President of JD Fashion where she was responsible for driving the fashion business covering apparel, shoes, sportswear, bags, jewelry, watches and accessories. She was also instrumental in leading JD.com’s M&A investment strategy to fuel strategic growth. Prior to joining JD.com, Ms. Ding served as Vice President of Retail Service at Nielsen in China from 2015 to 2017 where she was responsible for overseeing Nielsen’s retail services business. Ms. Ding started her career in 1995 with Hanesbrands, Inc., where she spent the first ten years in the U.S. headquarters in various finance and corporate development roles. In 2005, Hanesbrands appointed her as the VP/General Manager of China where she brought American lingerie brand Hanes and casualwear brand Champion into the China market.

Ms. Ding is a well-regarded e-commerce and digital leader and was recognized as Forbes 2018 TOP 100 Most Successful Businesswomen in China and Forbes 2017 TOP 10 Most Influential People in China Fashion Industry. Ms. Ding received a Bachelor of Chemistry degree from the Nanjing University of China. She also earned an M.B.A from the Wake Forest University in Winston-Salem, North Carolina USA.

What is Xia Ding's net worth?

The estimated net worth of Xia Ding is at least $27.80 thousand as of July 27th, 2023. Ding owns 1,421 shares of USANA Health Sciences stock worth more than $27,805 as of December 4th. This net worth approximation does not reflect any other investments that Ding may own. Learn More about Xia Ding's net worth.

How do I contact Xia Ding?

The corporate mailing address for Ding and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on Xia Ding's contact information.

Has Xia Ding been buying or selling shares of USANA Health Sciences?

Xia Ding has not been actively trading shares of USANA Health Sciences in the last ninety days. Most recently, Xia Ding sold 606 shares of the business's stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $65.60, for a transaction totalling $39,753.60. Following the completion of the sale, the director now directly owns 1,421 shares of the company's stock, valued at $93,217.60. Learn More on Xia Ding's trading history.

Who are USANA Health Sciences' active insiders?

USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), Xia Ding (Director), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), Kevin Guest (Chairman), G. Iiekking (CFO), Paul Jones (Insider), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Peggie Pelosi (Director), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.

Are insiders buying or selling shares of USANA Health Sciences?

In the last twelve months, insiders at the sold shares 15 times. They sold a total of 37,313 shares worth more than $1,093,343.07. The most recent insider tranaction occured on November, 10th when Director Frederic J Winssinger sold 2,000 shares worth more than $38,420.00. Insiders at USANA Health Sciences own 0.6% of the company. Learn More about insider trades at USANA Health Sciences.

Information on this page was last updated on 11/10/2025.

Xia Ding Insider Trading History at USANA Health Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2023Sell606$65.60$39,753.601,421View SEC Filing Icon  
See Full Table

Xia Ding Buying and Selling Activity at USANA Health Sciences

This chart shows Xia Ding's buying and selling at USANA Health Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

USANA Health Sciences Company Overview

USANA Health Sciences logo
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $19.57
Low: $19.51
High: $20.25

50 Day Range

MA: $21.42
Low: $18.69
High: $28.55

2 Week Range

Now: $19.57
Low: $18.48
High: $38.85

Volume

137,437 shs

Average Volume

193,987 shs

Market Capitalization

$357.68 million

P/E Ratio

22.24

Dividend Yield

N/A

Beta

0.66